Establishing the
Fundamental Building Blocks
You Need for Success
Moving from gene to the clinic—and then on to commercialization—means your team is focused on rapidly achieving key milestones.
establishing the fundamental building blocks you need for success
Moving from gene to the clinic—and then on to commercialization—means your team is focused on rapidly achieving key milestones.
But your bench-to-clinic journey is complicated, and there are several trends that could challenge your progress.
Molecules and their development are becoming more complex, with novel formats to treat more complicated diseases and multiple comorbidities.
You’re hindered by new competitive pressures—both in terms of other companies chasing the same indications and finite funding for a growing number of challengers.
Accelerated timelines have always been the norm, but today, biotechs have to work even faster to get their drug candidates to market.
In response, many firms turn to various suppliers who specialize in different elements of the development and manufacturing process. They believe that this will help them take advantage of expertise, save money, or because they are familiar partners from the past.

Successful biotechs are adopting a different approach. They’re shifting their focus from speed alone to maximizing their product’s future value, or to improve potential partnership opportunities.

 

By adopting a holistic approach to drug development you’ll have the fundamental building blocks you need for success.

 

This integrated, building-block approach gives you far more choice and flexibility, and you will create an optimal path from gene to the clinic for your molecule.

 

To achieve these benefits, you will have to successfully address 3 key business challenges.

© 2021 Lonza. All Rights Reserved.